Elizabeth A. Garofalo sold Acadia Pharmaceuticals ($ACAD) shares once on the open market in the last year, for a total of $41,560. Her most recent sale occurred on September 2, 2025. This activity ranks her 10,569th among 11,678 insiders by sale value, well below the average of $8.6 million across about 6.4 transactions. She made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 2, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | S | Common Stock | 1600 | $25.98 | 25,382.0000 | 166,362,000 | 5.93% | 0.00% |
| June 11, 2025 | Alector, Inc. | $ALEC | GAROFALO ELIZABETH A. | Not found | A | Stock Option (right to buy) | 9450 | $0.00 | 9,450.0000 | 99,085,888 | 9999.99% | 0.01% |
| June 11, 2025 | Alector, Inc. | $ALEC | GAROFALO ELIZABETH A. | Not found | A | Common Stock | 28700 | $0.00 | 89,950.0000 | 99,085,888 | 46.86% | 0.03% |
| June 5, 2025 | Xenon Pharmaceuticals Inc. | $XENE | GAROFALO ELIZABETH A. | Not found | A | Share Option (Right to Buy) | 17012 | $0.00 | 17,012.0000 | 77,894,643 | 9999.99% | 0.02% |
| June 5, 2025 | Xenon Pharmaceuticals Inc. | $XENE | GAROFALO ELIZABETH A. | Not found | A | Restricted Share Units | 2645 | $0.00 | 2,645.0000 | 77,894,643 | 9999.99% | 0.00% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | M | Restricted Stock Units | 9387 | $0.00 | 0.0000 | 166,362,000 | 100.00% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | A | Restricted Stock Units | 8107 | $0.00 | 8,107.0000 | 166,362,000 | 9999.99% | 0.00% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | M | Common Stock | 9387 | $0.00 | 26,982.0000 | 166,362,000 | 53.35% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | A | Director Stock Options (Right to Buy) | 13793 | $0.00 | 13,793.0000 | 166,362,000 | 9999.99% | 0.01% |
| March 5, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | S | Common Stock | 4919 | $18.23 | 17,595.0000 | 166,362,000 | 21.85% | 0.00% |
| June 12, 2024 | Alector, Inc. | $ALEC | GAROFALO ELIZABETH A. | Not found | A | Common Stock | 35000 | $0.00 | 61,250.0000 | 0 | 133.33% | 0.00% |
| June 5, 2024 | Xenon Pharmaceuticals Inc. | $XENE | GAROFALO ELIZABETH A. | Not found | A | Stock Option (Right to Buy) | 15542 | $0.00 | 15,542.0000 | 66,889,005 | 9999.99% | 0.02% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | M | Restricted Stock Units | 6652 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | M | Common Stock | 6652 | $0.00 | 22,514.0000 | 163,819,000 | 41.94% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | A | Director Stock Options (Right to Buy) | 15959 | $0.00 | 15,959.0000 | 163,819,000 | 9999.99% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Not found | A | Restricted Stock Units | 9387 | $0.00 | 9,387.0000 | 163,819,000 | 9999.99% | 0.01% |
| March 8, 2024 | Xenon Pharmaceuticals Inc. | $XENE | GAROFALO ELIZABETH A. | Not found | M | Common Shares | 3500 | $18.56 | 3,500.0000 | 66,889,005 | 9999.99% | 0.01% |
| March 8, 2024 | Xenon Pharmaceuticals Inc. | $XENE | GAROFALO ELIZABETH A. | Not found | M | Stock Option (Right to Buy) | 3500 | $0.00 | 16,500.0000 | 66,889,005 | 17.50% | 0.01% |
| March 8, 2024 | Xenon Pharmaceuticals Inc. | $XENE | GAROFALO ELIZABETH A. | Not found | S | Common Shares | 2092 | $45.69 | 0.0000 | 66,889,005 | 100.00% | 0.00% |
| March 8, 2024 | Xenon Pharmaceuticals Inc. | $XENE | GAROFALO ELIZABETH A. | Not found | F | Common Shares | 1408 | $46.16 | 2,092.0000 | 66,889,005 | 40.23% | 0.00% |
| Dec. 5, 2023 | Alector, Inc. | $ALEC | GAROFALO ELIZABETH A. | Not found | G | Common Stock | 9459 | $0.00 | 26,250.0000 | 0 | 26.49% | 0.00% |
| Nov. 24, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | G | Common Stock | 2918 | $0.00 | 15,862.0000 | 161,683,000 | 15.54% | 0.00% |
| June 14, 2023 | Alector, Inc. | $ALEC | GAROFALO ELIZABETH A. | Not found | A | Common Stock | 26250 | $0.00 | 35,709.0000 | 0 | 277.51% | 0.00% |
| June 14, 2023 | Alector, Inc. | $ALEC | GAROFALO ELIZABETH A. | Not found | A | Stock Option (right to buy) | 12360 | $0.00 | 12,360.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | M | Restricted Stock Units | 8552 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | A | Director Stock Options (Right to Buy) | 11045 | $0.00 | 11,045.0000 | 161,683,000 | 9999.99% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | A | Restricted Stock Units | 6652 | $0.00 | 6,652.0000 | 161,683,000 | 9999.99% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | M | Common Stock | 6391 | $0.00 | 8,309.0000 | 0 | 333.21% | 0.00% |
| Sept. 29, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | M | Common Stock | 1919 | $0.00 | 10,228.0000 | 0 | 23.10% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | M | Common Stock | 8552 | $0.00 | 18,780.0000 | 161,683,000 | 83.61% | 0.01% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | M | Restricted Stock Units | 6391 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 29, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | GAROFALO ELIZABETH A. | Director | M | Restricted Stock Units | 1919 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |